investor_platform
OverviewEntitiesEventsSearch
back to entities

Eris Lifesciences

Company|Added Feb 25, 2026

Also known as: ERIS

PharmaceuticalsHealthcare

Events(1)

Natco Pharma Clarification on Semaglutide Deal with Eris Lifesciences
regulatory_filing
Positive

Natco Pharma Limited submitted a response to the NSE clarifying news regarding a commercial agreement with Eris Lifesciences for the weight-loss drug semaglutide.

confidence: 95%

Related Entities(1)

Natco Pharma Limited
Company
PharmaceuticalsHealthcare
investor_platform

Real-time investor intelligence. Companies, funding rounds, and market events — structured and searchable.

Product

  • Search
  • Entities
  • Events
  • API Docs

Company

  • About
  • Pricing
  • Terms
  • Privacy

Connect

  • Status
  • Support

© 2026 Investor Platform

all systems operational